MedCap AB (publ)
STO:MCAP

Watchlist Manager
MedCap AB (publ) Logo
MedCap AB (publ)
STO:MCAP
Watchlist
Price: 541 SEK -4.25% Market Closed
Market Cap: 8B SEK
Have any thoughts about
MedCap AB (publ)?
Write Note

MedCap AB (publ)
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MedCap AB (publ)
Capital Expenditures Peer Comparison

Comparables:
ALIF B
BICO
BIOT
G
GENO
M
MAGLE

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
MedCap AB (publ)
STO:MCAP
Capital Expenditures
-kr57.8m
CAGR 3-Years
-22%
CAGR 5-Years
-50%
CAGR 10-Years
-21%
AddLife AB
STO:ALIF B
Capital Expenditures
-kr308m
CAGR 3-Years
-49%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Capital Expenditures
-kr291.2m
CAGR 3-Years
-30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Capital Expenditures
-kr163m
CAGR 3-Years
-37%
CAGR 5-Years
-31%
CAGR 10-Years
-17%
G
Genovis AB
STO:GENO
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Magle Chemoswed Holding AB
STO:MAGLE
Capital Expenditures
-kr15.1m
CAGR 3-Years
-24%
CAGR 5-Years
6%
CAGR 10-Years
N/A

See Also

What is MedCap AB (publ)'s Capital Expenditures?
Capital Expenditures
-57.8m SEK

Based on the financial report for Sep 30, 2024, MedCap AB (publ)'s Capital Expenditures amounts to -57.8m SEK.

What is MedCap AB (publ)'s Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-21%

Over the last year, the Capital Expenditures growth was -55%. The average annual Capital Expenditures growth rates for MedCap AB (publ) have been -22% over the past three years , -50% over the past five years , and -21% over the past ten years .

Back to Top